Abbott CEO Robert Ford didn't exactly show all of his cards during the company's latest earnings call, but he did hint that there may be some merger and acquisition (M&A) activity in 2022.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,